{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:37:27Z","timestamp":1783226247425,"version":"3.54.6"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82302982"],"award-info":[{"award-number":["No. 82302982"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.32141004"],"award-info":[{"award-number":["NO.32141004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["No. SBK2023042075"],"award-info":[{"award-number":["No. SBK2023042075"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No. 2022YFC3601800"],"award-info":[{"award-number":["No. 2022YFC3601800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The CAMS Innovation Fund for Medical Science","award":["No. 2021-I2M-1-059"],"award-info":[{"award-number":["No. 2021-I2M-1-059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09030-9","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:38:57Z","timestamp":1740148737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases"],"prefix":"10.1007","volume":"68","author":[{"given":"Liming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"1","key":"9030_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","volume":"181","author":"L Fugger","year":"2020","unstructured":"Fugger L, Jensen LT, Rossjohn J (2020) Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell 181(1):63\u201380","journal-title":"Cell"},{"issue":"4","key":"9030_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang FS, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278(4):369\u2013395","journal-title":"J Intern Med"},{"issue":"6644","key":"9030_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.adg2992","volume":"380","author":"A Harroud","year":"2023","unstructured":"Harroud A, Hafler DA (2023) Common genetic factors among autoimmune diseases. Science (New York, NY) 380(6644):485\u2013490","journal-title":"Science (New York, NY)"},{"issue":"8","key":"9030_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky DS (2023) Pathogenesis of autoimmune disease. Nat Rev Nephrol 19(8):509\u2013524","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"9030_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345(5):340\u2013350","journal-title":"N Engl J Med"},{"issue":"4","key":"9030_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","volume":"13","author":"JF Swart","year":"2017","unstructured":"Swart JF, Delemarre EM, van Wijk F et al (2017) Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol 13(4):244\u2013256","journal-title":"Nat Rev Rheumatol"},{"key":"9030_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","volume":"72","author":"T Alexander","year":"2021","unstructured":"Alexander T, Greco R, Snowden JA (2021) Hematopoietic stem cell transplantation for autoimmune disease. Annu Rev Med 72:215\u2013228","journal-title":"Annu Rev Med"},{"key":"9030_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108409","volume":"102","author":"SA Beheshti","year":"2022","unstructured":"Beheshti SA, Shamsasenjan K, Ahmadi M et al (2022) CAR Treg: a new approach in the treatment of autoimmune diseases. Int Immunopharmacol 102:108409","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"9030_CR9","first-page":"125","volume":"35","author":"S Al-Ghadban","year":"2020","unstructured":"Al-Ghadban S, Bunnell BA (2020) Adipose tissue-derived stem cells: immunomodulatory effects and therapeutic potential. Physiology (Bethesda) 35(2):125\u2013133","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"9030_CR10","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393\u2013403","journal-title":"Cell Tissue Kinet"},{"issue":"5","key":"9030_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI (1991) Mesenchymal stem cells. Journal of orthopaedic research\u202f: official publication of the Orthopaedic Research Society 9(5):641\u2013650","journal-title":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society"},{"key":"9030_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","volume":"60","author":"M Timaner","year":"2020","unstructured":"Timaner M, Tsai KK, Shaked Y (2020) The multifaceted role of mesenchymal stem cells in cancer. Semin Cancer Biol 60:225\u2013237","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"9030_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102755","volume":"20","author":"D Farge","year":"2021","unstructured":"Farge D, Loisel S, Lansiaux P et al (2021) Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev 20(3):102755","journal-title":"Autoimmun Rev"},{"key":"9030_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667221","volume":"12","author":"D Kim","year":"2021","unstructured":"Kim D, Lee AE, Xu Q et al (2021) Gingiva-derived mesenchymal stem cells: potential application in tissue engineering and regenerative medicine - a comprehensive review. Front Immunol 12:667221","journal-title":"Front Immunol"},{"key":"9030_CR15","doi-asserted-by":"crossref","unstructured":"Papait A, Vertua E, Magatti M, et al. (2020) Mesenchymal stromal cells from fetal and maternal placenta possess key similarities and differences: potential implications for their applications in regenerative medicine. Cells;9(1).","DOI":"10.3390\/cells9010127"},{"issue":"10","key":"9030_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.5966\/sctm.2015-0022","volume":"4","author":"PL Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez PL, Carvajal C, Cuenca J et al (2015) Chorion mesenchymal stem cells show superior differentiation, immunosuppressive, and angiogenic potentials in comparison with haploidentical maternal placental cells. Stem Cells Transl Med 4(10):1109\u20131121","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"9030_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ et al (2022) Stem cell-based therapy for human diseases. Signal Transduct Target Ther 7(1):272","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"9030_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.stem.2022.10.001","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Fang J, Liu B et al (2022) Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell 29(11):1515\u20131530","journal-title":"Cell Stem Cell"},{"issue":"10","key":"9030_CR19","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1096\/fj.08-126946","volume":"23","author":"S Baglioni","year":"2009","unstructured":"Baglioni S, Francalanci M, Squecco R et al (2009) Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 23(10):3494\u20133505","journal-title":"FASEB J"},{"issue":"1","key":"9030_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan T, Luo M, Wei X (2021) Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol 14(1):195","journal-title":"J Hematol Oncol"},{"issue":"1","key":"9030_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11\u201315","journal-title":"Cell Stem Cell"},{"issue":"2","key":"9030_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.biomaterials.2010.08.101","volume":"32","author":"EL Fong","year":"2011","unstructured":"Fong EL, Chan CK, Goodman SB (2011) Stem cell homing in musculoskeletal injury. Biomaterials 32(2):395\u2013409","journal-title":"Biomaterials"},{"issue":"1","key":"9030_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J et al (2021) Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol 14(1):24","journal-title":"J Hematol Oncol"},{"issue":"1","key":"9030_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13287-021-02265-1","volume":"12","author":"A Markov","year":"2021","unstructured":"Markov A, Thangavelu L, Aravindhan S et al (2021) Mesenchymal stem\/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 12(1):192","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"9030_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q et al (2018) Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol 14(8):493\u2013507","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"9030_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K (2020) Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci 41(9):653\u2013664","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9030_CR27","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1038\/s41598-017-04766-7","volume":"7","author":"WJ Song","year":"2017","unstructured":"Song WJ, Li Q, Ryu MO et al (2017) TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates DSS-induced colitis by inducing M2 macrophage polarization in mice. Sci Rep 7(1):5187","journal-title":"Sci Rep"},{"issue":"4","key":"9030_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","volume":"14","author":"N Molnarfi","year":"2015","unstructured":"Molnarfi N, Benkhoucha M, Funakoshi H et al (2015) Hepatocyte growth factor: a regulator of inflammation and autoimmunity. Autoimmun Rev 14(4):293\u2013303","journal-title":"Autoimmun Rev"},{"key":"9030_CR29","doi-asserted-by":"crossref","unstructured":"Ghannam S, P\u00e8ne J, Moquet-Torcy G, et al. (2010) Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Journal of immunology (Baltimore, Md : 1950);185(1):302\u201312.","DOI":"10.4049\/jimmunol.0902007"},{"issue":"9","key":"9030_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41419-024-07024-7","volume":"15","author":"Q Ni","year":"2024","unstructured":"Ni Q, Zhen L, Zeng Z et al (2024) Mesenchymal stromal cells restrain the Th17 cell response via L-amino-acid oxidase within lymph nodes. Cell Death Dis 15(9):640","journal-title":"Cell Death Dis"},{"issue":"9","key":"9030_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9):726\u2013736","journal-title":"Nat Rev Immunol"},{"key":"9030_CR32","doi-asserted-by":"crossref","unstructured":"Papait A, Vertua E, Signoroni PB, et al. (2023) Amniotic MSC affect CD8 naive polarization toward SLEC\/MPEC subsets by down-modulating IL-12R\u03b21 and IL-2R\u03b1 signaling pathways. iScience;26(12):108483.","DOI":"10.1016\/j.isci.2023.108483"},{"issue":"1","key":"9030_CR33","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13287-024-03980-1","volume":"15","author":"L Vaillant","year":"2024","unstructured":"Vaillant L, Akhter W, Nakhle J et al (2024) The role of mitochondrial transfer in the suppression of CD8(+) T cell responses by mesenchymal stem cells. Stem Cell Res Ther 15(1):394","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"9030_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32(3):252\u2013260","journal-title":"Nat Biotechnol"},{"key":"9030_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH (2019) Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol 10:1191","journal-title":"Front Immunol"},{"issue":"10","key":"9030_CR36","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.stem.2021.09.006","volume":"28","author":"M Krampera","year":"2021","unstructured":"Krampera M, Le Blanc K (2021) Mesenchymal stromal cells: putative microenvironmental modulators become cell therapy. Cell Stem Cell 28(10):1708\u20131725","journal-title":"Cell Stem Cell"},{"key":"9030_CR37","doi-asserted-by":"crossref","unstructured":"Galleu A, Riffo-Vasquez Y, Trento C, et al. (2017) Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Science translational medicine;9(416).","DOI":"10.1126\/scitranslmed.aam7828"},{"issue":"1","key":"9030_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wu Y, Xu Y et al (2022) Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer 21(1):179","journal-title":"Mol Cancer"},{"issue":"1","key":"9030_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","volume":"14","author":"Z Weng","year":"2021","unstructured":"Weng Z, Zhang B, Wu C et al (2021) Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 14(1):136","journal-title":"J Hematol Oncol"},{"key":"9030_CR40","doi-asserted-by":"crossref","unstructured":"Franco da Cunha F, Andrade-Oliveira V, Candido de Almeida D, et al. (2020) Extracellular vesicles isolated from mesenchymal stromal cells modulate CD4(+) T lymphocytes toward a regulatory profile. Cells;9(4).","DOI":"10.3390\/cells9041059"},{"issue":"21","key":"9030_CR41","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1089\/scd.2014.0091","volume":"23","author":"A Conforti","year":"2014","unstructured":"Conforti A, Scarsella M, Starc N et al (2014) Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem cells and development 23(21):2591\u20132599","journal-title":"Stem cells and development"},{"key":"9030_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960909","volume":"13","author":"A Papait","year":"2022","unstructured":"Papait A, Ragni E, Cargnoni A et al (2022) Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective. Front Immunol 13:960909","journal-title":"Front Immunol"},{"issue":"1","key":"9030_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13287-023-03432-2","volume":"14","author":"F Guo","year":"2023","unstructured":"Guo F, Pan Q, Chen T et al (2023) hUC-MSC transplantation therapy effects on lupus-prone MRL\/lpr mice at early disease stages. Stem Cell Res Ther 14(1):211","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109699","volume":"117","author":"A Hoseinzadeh","year":"2023","unstructured":"Hoseinzadeh A, Rezaieyazdi Z, Mahmoudi M et al (2023) Dysregulated balance in Th17\/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic? Int Immunopharmacol 117:109699","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"9030_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3727\/096368910X520056","volume":"20","author":"JW Chang","year":"2011","unstructured":"Chang JW, Hung SP, Wu HH et al (2011) Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant 20(2):245\u2013257","journal-title":"Cell Transplant"},{"issue":"3","key":"9030_CR46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.clim.2011.08.014","volume":"141","author":"B Zhou","year":"2011","unstructured":"Zhou B, Yuan J, Zhou Y et al (2011) Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clinical immunology (Orlando, Fla) 141(3):328\u2013337","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"14","key":"9030_CR47","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"LA Ortiz","year":"2003","unstructured":"Ortiz LA, Gambelli F, McBride C et al (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100(14):8407\u20138411","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9030_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/art.39477","volume":"68","author":"AT Maria","year":"2016","unstructured":"Maria AT, Toupet K, Bony C et al (2016) Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis & rheumatology (Hoboken, NJ) 68(4):1013\u20131025","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"4","key":"9030_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/cr.2017.11","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Wang D, Moshaverinia A et al (2017) Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res 27(4):559\u2013577","journal-title":"Cell Res"},{"key":"9030_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.imlet.2020.05.005","volume":"225","author":"Y Xin","year":"2020","unstructured":"Xin Y, Gao J, Hu R et al (2020) Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation. Immunol Lett 225:66\u201373","journal-title":"Immunol Lett"},{"key":"9030_CR51","doi-asserted-by":"publisher","first-page":"6961052","DOI":"10.1155\/2019\/6961052","volume":"2019","author":"M Chen","year":"2019","unstructured":"Chen M, Peng J, Xie Q et al (2019) Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs). Stem Cells International 2019:6961052","journal-title":"Stem Cells International"},{"issue":"1","key":"9030_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-016-0376-2","volume":"7","author":"K Chao","year":"2016","unstructured":"Chao K, Zhang S, Qiu Y et al (2016) Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells. Stem Cell Res Ther 7(1):109","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.604021","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Ma K, Zhang L et al (2020) Human umbilical cord blood derived-mesenchymal stem cells alleviate dextran sulfate sodium-induced colitis by increasing regulatory T cells in mice. Frontiers in Cell and Developmental Biology 8:604021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"9030_CR54","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bbrc.2004.10.091","volume":"325","author":"N Ende","year":"2004","unstructured":"Ende N, Chen R, Reddi AS (2004) Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 325(3):665\u2013669","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9030_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13287-019-1348-0","volume":"10","author":"M Park","year":"2019","unstructured":"Park M, Banga JP, Kim GJ et al (2019) Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves\u2019 ophthalmopathy. Stem Cell Res Ther 10(1):246","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9030_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-018-0979-x","volume":"9","author":"J Fan","year":"2018","unstructured":"Fan J, Tang X, Wang Q et al (2018) Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. Stem Cell Res Ther 9(1):237","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR57","doi-asserted-by":"crossref","unstructured":"Chen Y, Chen S, Liu LY, et al. (2014) Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway. Immunology letters;162(2 Pt B):222\u20138.","DOI":"10.1016\/j.imlet.2014.10.021"},{"issue":"15","key":"9030_CR58","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, Wang D, Liu D et al (2012) Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood 120(15):3142\u20133151","journal-title":"Blood"},{"key":"9030_CR59","doi-asserted-by":"crossref","unstructured":"Kiriakidou M, Ching CL. (2020) Systemic lupus erythematosus. Annals of internal medicine;172(11):Itc81-itc96.","DOI":"10.7326\/AITC202006020"},{"issue":"10188","key":"9030_CR60","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet (London, England) 393(10188):2332\u20132343","journal-title":"Lancet (London, England)"},{"key":"9030_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843192","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Luo M, Li B et al (2022) Immunomodulatory Activity of Mesenchymal stem cells in lupus nephritis: advances and applications. Front Immunol 13:843192","journal-title":"Front Immunol"},{"issue":"2","key":"9030_CR62","first-page":"79","volume":"7","author":"W Li","year":"2021","unstructured":"Li W, Chen W, Sun L (2021) An update for mesenchymal stem cell therapy in lupus nephritis. Kidney diseases (Basel, Switzerland) 7(2):79\u201389","journal-title":"Kidney diseases (Basel, Switzerland)"},{"issue":"6","key":"9030_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/cmi.2008.52","volume":"5","author":"K Zhou","year":"2008","unstructured":"Zhou K, Zhang H, Jin O et al (2008) Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice. Cell Mol Immunol 5(6):417\u2013424","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"9030_CR64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H et al (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem cells (Dayton, Ohio) 27(6):1421\u20131432","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"9030_CR65","doi-asserted-by":"crossref","unstructured":"Chua AWC, Guo D, Tan JC, et al. (2022) Intraperitoneally delivered umbilical cord lining mesenchymal stromal cells improve survival and kidney function in murine lupus via myeloid pathway targeting. International Journal of Molecular Sciences;24(1).","DOI":"10.3390\/ijms24010365"},{"issue":"1","key":"9030_CR66","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13287-022-03002-y","volume":"13","author":"G Yao","year":"2022","unstructured":"Yao G, Qi J, Li X et al (2022) Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs. Stem Cell Res Ther 13(1):328","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"9030_CR67","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24499","volume":"60","author":"J Yang","year":"2009","unstructured":"Yang J, Chu Y, Yang X et al (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60(5):1472\u20131483","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9030_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0961203317711013","volume":"27","author":"X Yang","year":"2018","unstructured":"Yang X, Yang J, Li X et al (2018) Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice. Lupus 27(1):49\u201359","journal-title":"Lupus"},{"issue":"3","key":"9030_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegr\u00eda J et al (2013) Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4(3):65","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"9030_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang D, Huang S, Yuan X et al (2017) The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol 14(5):423\u2013431","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"9030_CR71","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13287-024-03834-w","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Wu F, Mao J et al (2024) Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses. Stem Cell Res Ther 15(1):216","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"9030_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon M, Blair PA, Isenberg DA et al (2016) A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44(3):683\u2013697","journal-title":"Immunity"},{"issue":"1","key":"9030_CR73","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s13287-021-02586-1","volume":"12","author":"W Chun","year":"2021","unstructured":"Chun W, Tian J, Zhang Y (2021) Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-\u03b21. Stem Cell Res Ther 12(1):512","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"9030_CR74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2015.07.011","volume":"161","author":"W Deng","year":"2015","unstructured":"Deng W, Chen W, Zhang Z et al (2015) Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus. Clinical immunology (Orlando, Fla) 161(2):209\u2013216","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"1","key":"9030_CR75","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","volume":"10","author":"X Yuan","year":"2019","unstructured":"Yuan X, Qin X, Wang D et al (2019) Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients. Nat Commun 10(1):2498","journal-title":"Nat Commun"},{"key":"9030_CR76","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","volume":"45","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Huang S, Wu S et al (2019) Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. EBioMedicine 45:341\u2013350","journal-title":"EBioMedicine"},{"key":"9030_CR77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.05.034","volume":"32","author":"H Ma","year":"2018","unstructured":"Ma H, Liu C, Shi B et al (2018) Mesenchymal stem cells control complement C5 activation by factor H in lupus nephritis. EBioMedicine 32:21\u201330","journal-title":"EBioMedicine"},{"issue":"1","key":"9030_CR78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41392-024-02018-5","volume":"9","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Shan Y, Shen L et al (2024) Renal remodeling by CXCL10-CXCR3 axis-recruited mesenchymal stem cells and subsequent IL4I1 secretion in lupus nephritis. Signal Transduct Target Ther 9(1):325","journal-title":"Signal Transduct Target Ther"},{"key":"9030_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111256","volume":"126","author":"H Yu","year":"2024","unstructured":"Yu H, Li Q, Zhu H et al (2024) Mesenchymal stem cells attenuate systemic lupus erythematosus by inhibiting NLRP3 inflammasome activation through Pim-1 kinase. Int Immunopharmacol 126:111256","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"9030_CR80","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jama.2022.0786","volume":"327","author":"MH Smith","year":"2022","unstructured":"Smith MH, Berman JR (2022) What is rheumatoid arthritis? JAMA 327(12):1194","journal-title":"JAMA"},{"key":"9030_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103427","volume":"69","author":"M Lopez-Santalla","year":"2021","unstructured":"Lopez-Santalla M, Bueren JA, Garin MI (2021) Mesenchymal stem\/stromal cell-based therapy for the treatment of rheumatoid arthritis: an update on preclinical studies. EBioMedicine 69:103427","journal-title":"EBioMedicine"},{"key":"9030_CR82","doi-asserted-by":"publisher","first-page":"1001598","DOI":"10.3389\/fimmu.2022.1001598","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Niu Q et al (2022) Bibliometric and visualization analysis of mesenchymal stem cells and rheumatoid arthritis (from 2012 to 2021). Front Immunol 13:1001598","journal-title":"Front Immunol"},{"key":"9030_CR83","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ebiom.2019.08.073","volume":"47","author":"L Liu","year":"2019","unstructured":"Liu L, Wong CW, Han M et al (2019) Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis. EBioMedicine 47:563\u2013577","journal-title":"EBioMedicine"},{"key":"9030_CR84","doi-asserted-by":"crossref","unstructured":"Sarsenova M, Issabekova A, Abisheva S, et al. (2021) Mesenchymal stem cell-based therapy for rheumatoid arthritis. International Journal of Molecular Sciences;22(21).","DOI":"10.3390\/ijms222111592"},{"key":"9030_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643170","volume":"12","author":"JJ El-Jawhari","year":"2021","unstructured":"El-Jawhari JJ, El-Sherbiny Y, McGonagle D et al (2021) Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Front Immunol 12:643170","journal-title":"Front Immunol"},{"issue":"1","key":"9030_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13287-021-02158-3","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Wu M, You M et al (2021) The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther 12(1):103","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR87","doi-asserted-by":"crossref","unstructured":"Shimizu Y, Ntege EH, Azuma C, et al. (2023) Management of rheumatoid arthritis: possibilities and challenges of mesenchymal stromal\/stem cell-based therapies. Cells;12(14).","DOI":"10.3390\/cells12141905"},{"issue":"3","key":"9030_CR88","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/stem.1881","volume":"33","author":"M Franquesa","year":"2015","unstructured":"Franquesa M, Mensah FK, Huizinga R et al (2015) Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem cells (Dayton, Ohio) 33(3):880\u2013891","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"4","key":"9030_CR89","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","volume":"19","author":"JE Pope","year":"2023","unstructured":"Pope JE, Denton CP, Johnson SR et al (2023) State-of-the-art evidence in the treatment of systemic sclerosis. Nat Rev Rheumatol 19(4):212\u2013226","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"9030_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41584-022-00765-9","volume":"18","author":"AL Herrick","year":"2022","unstructured":"Herrick AL, Assassi S, Denton CP (2022) Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need. Nat Rev Rheumatol 18(5):276\u2013285","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"9030_CR91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-016-8552-9","volume":"52","author":"AT Maria","year":"2017","unstructured":"Maria AT, Maumus M, Le Quellec A et al (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allergy Immunol 52(2):234\u2013259","journal-title":"Clin Rev Allergy Immunol"},{"issue":"26","key":"9030_CR92","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz LA, Dutreil M, Fattman C et al (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104(26):11002\u201311007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9030_CR93","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ et al (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54\u201363","journal-title":"Cell Stem Cell"},{"issue":"1","key":"9030_CR94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1465-9921-11-16","volume":"11","author":"SH Lee","year":"2010","unstructured":"Lee SH, Jang AS, Kim YE et al (2010) Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury\/fibrosis. Respir Res 11(1):16","journal-title":"Respir Res"},{"issue":"3","key":"9030_CR95","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s12016-021-08892-z","volume":"64","author":"X Zhuang","year":"2023","unstructured":"Zhuang X, Hu X, Zhang S et al (2023) Mesenchymal stem cell-based therapy as a new approach for the treatment of systemic sclerosis. Clin Rev Allergy Immunol 64(3):284\u2013320","journal-title":"Clin Rev Allergy Immunol"},{"issue":"20","key":"9030_CR96","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R (2022) What is multiple sclerosis? JAMA 328(20):2078","journal-title":"JAMA"},{"issue":"5","key":"9030_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrneurol.2010.35","volume":"6","author":"G Martino","year":"2010","unstructured":"Martino G, Franklin RJ, Baron Van Evercooren A et al (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nat Rev Neurol 6(5):247\u2013255","journal-title":"Nat Rev Neurol"},{"key":"9030_CR98","doi-asserted-by":"crossref","unstructured":"Gugliandolo A, Bramanti P, Mazzon E. (2020) Mesenchymal stem cells in multiple sclerosis: recent evidence from pre-clinical to clinical studies. International Journal of Molecular Sciences;21(22).","DOI":"10.3390\/ijms21228662"},{"issue":"7","key":"9030_CR99","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/scd.2012.0463","volume":"22","author":"R Liu","year":"2013","unstructured":"Liu R, Zhang Z, Lu Z et al (2013) Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Stem cells and development 22(7):1053\u20131062","journal-title":"Stem cells and development"},{"key":"9030_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0253-4","volume":"7","author":"O Trubiani","year":"2016","unstructured":"Trubiani O, Giacoppo S, Ballerini P et al (2016) Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis. Stem Cell Res Ther 7:1","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"9030_CR101","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000351450","volume":"20","author":"Y Guo","year":"2013","unstructured":"Guo Y, Chan KH, Lai WH et al (2013) Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis. NeuroImmunoModulation 20(5):294\u2013303","journal-title":"NeuroImmunoModulation"},{"issue":"4","key":"9030_CR102","first-page":"2516","volume":"11","author":"S Liu","year":"2019","unstructured":"Liu S, Wang J, Han R et al (2019) Therapeutic effect of transplanted umbilical cord mesenchymal stem cells in a cynomolgus monkey model of multiple sclerosis. American Journal of Translational Research 11(4):2516\u20132531","journal-title":"American Journal of Translational Research"},{"issue":"7","key":"9030_CR103","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","volume":"10","author":"A Uccelli","year":"2011","unstructured":"Uccelli A, Laroni A, Freedman MS (2011) Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. The Lancet Neurology 10(7):649\u2013656","journal-title":"The Lancet Neurology"},{"issue":"15","key":"9030_CR104","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1089\/scd.2016.0020","volume":"25","author":"P Abramowski","year":"2016","unstructured":"Abramowski P, Krasemann S, Ernst T et al (2016) Mesenchymal stromal\/stem cells do not ameliorate experimental autoimmune encephalomyelitis and are not detectable in the central nervous system of transplanted mice. Stem cells and development 25(15):1134\u20131148","journal-title":"Stem cells and development"},{"key":"9030_CR105","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2015.06.024","volume":"50","author":"L Salinas Tejedor","year":"2015","unstructured":"Salinas Tejedor L, Berner G, Jacobsen K et al (2015) Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system. Brain Behav Immun 50:155\u2013165","journal-title":"Brain Behav Immun"},{"issue":"6","key":"9030_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01857","volume":"5","author":"LL Pinheiro","year":"2019","unstructured":"Pinheiro LL, de Lima AR, Martins DM et al (2019) Mesenchymal stem cells in dogs with demyelinating leukoencephalitis as an experimental model of multiple sclerosis. Heliyon 5(6):e01857","journal-title":"Heliyon"},{"issue":"10281","key":"9030_CR107","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE et al (2021) Psoriasis. Lancet (London, England) 397(10281):1301\u20131315","journal-title":"Lancet (London, England)"},{"issue":"7","key":"9030_CR108","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/ced.14269","volume":"45","author":"A Paganelli","year":"2020","unstructured":"Paganelli A, Tarentini E, Benassi L et al (2020) Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review. Clin Exp Dermatol 45(7):824\u2013830","journal-title":"Clin Exp Dermatol"},{"key":"9030_CR109","doi-asserted-by":"crossref","unstructured":"Diotallevi F, Di Vincenzo M, Martina E, et al. (2022) Mesenchymal stem cells and psoriasis: systematic review. International Journal of Molecular Sciences;23(23).","DOI":"10.3390\/ijms232315080"},{"key":"9030_CR110","doi-asserted-by":"publisher","first-page":"6544514","DOI":"10.1155\/2022\/6544514","volume":"2022","author":"Z Ye","year":"2022","unstructured":"Ye Z, Liang Y, Lin B et al (2022) Gingiva-derived mesenchymal stem cells attenuate imiquimod- (IMQ-) induced murine psoriasis-like skin inflammation. Stem Cells International 2022:6544514","journal-title":"Stem Cells International"},{"issue":"3","key":"9030_CR111","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10753-023-01785-7","volume":"46","author":"X Ren","year":"2023","unstructured":"Ren X, Zhong W, Li W et al (2023) Human umbilical cord-derived mesenchymal stem cells alleviate psoriasis through TNF-\u03b1\/NF-\u03baB\/MMP13 pathway. Inflammation 46(3):987\u20131001","journal-title":"Inflammation"},{"key":"9030_CR112","doi-asserted-by":"crossref","unstructured":"Zhang B, Lai RC, Sim WK, et al. (2021) Topical application of mesenchymal stem cell exosomes alleviates the imiquimod induced psoriasis-like inflammation. International Journal of Molecular Sciences;22(2).","DOI":"10.3390\/ijms22020720"},{"issue":"6","key":"9030_CR113","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1007\/s12015-023-10556-8","volume":"19","author":"Z Wang","year":"2023","unstructured":"Wang Z, Hu Y, Wang X et al (2023) Comparative analysis of the therapeutic effects of fresh and cryopreserved human umbilical cord derived mesenchymal stem cells in the treatment of psoriasis. Stem cell reviews and reports 19(6):1922\u20131936","journal-title":"Stem cell reviews and reports"},{"key":"9030_CR114","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/IJN.S355366","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Lei B, Zhang E et al (2022) Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics. Int J Nanomed 17:1757\u20131781","journal-title":"Int J Nanomed"},{"issue":"1","key":"9030_CR115","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s13287-021-02533-0","volume":"12","author":"R Wang","year":"2021","unstructured":"Wang R, Yao Q, Chen W et al (2021) Stem cell therapy for Crohn\u2019s disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 12(1):463","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"9030_CR116","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez MA, Gonzalez-Rey E, Rico L et al (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136(3):978\u2013989","journal-title":"Gastroenterology"},{"issue":"1","key":"9030_CR117","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13287-023-03471-9","volume":"14","author":"A Liu","year":"2023","unstructured":"Liu A, Liang X, Wang W et al (2023) Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis. Stem Cell Res Ther 14(1):271","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"9030_CR118","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41419-019-1957-7","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Feng R, Fu Q et al (2019) Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-\u03b1-stimulated gene-6 in inflammatory bowel disease models. Cell Death Dis 10(10):718","journal-title":"Cell Death Dis"},{"key":"9030_CR119","doi-asserted-by":"crossref","unstructured":"Usunier B, Brossard C, L\u2019Homme B, et al. (2021) HGF and TSG-6 released by mesenchymal stem cells attenuate colon radiation-induced fibrosis. International Journal of Molecular Sciences;22(4).","DOI":"10.3390\/ijms22041790"},{"key":"9030_CR120","doi-asserted-by":"crossref","unstructured":"Fang J, Hou P, Liu S, et al. (2023) NAD(+) salvage governs the immunosuppressive capacity of mesenchymal stem cells. Cellular and Molecular Immunology.","DOI":"10.1038\/s41423-023-01073-2"},{"issue":"9","key":"9030_CR121","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG (2023) Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol 19(9):542\u2013554","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"9030_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.diabet.2008.10.003","volume":"35","author":"L Vija","year":"2009","unstructured":"Vija L, Farge D, Gautier JF et al (2009) Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab 35(2):85\u201393","journal-title":"Diabetes Metab"},{"issue":"4","key":"9030_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.10.033","volume":"1866","author":"JS Pixley","year":"2020","unstructured":"Pixley JS (2020) Mesenchymal stem cells to treat type 1 diabetes. Biochim Biophys Acta 1866(4):165315","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"9030_CR124","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12565-020-00550-2","volume":"95","author":"A El-Kersh","year":"2020","unstructured":"El-Kersh A, El-Akabawy G, Al-Serwi RH (2020) Transplantation of human dental pulp stem cells in streptozotocin-induced diabetic rats. Anat Sci Int 95(4):523\u2013539","journal-title":"Anat Sci Int"},{"issue":"7","key":"9030_CR125","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-022-05708-3","volume":"65","author":"E Kawada-Horitani","year":"2022","unstructured":"Kawada-Horitani E, Kita S, Okita T et al (2022) Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade. Diabetologia 65(7):1185\u20131197","journal-title":"Diabetologia"},{"issue":"1","key":"9030_CR126","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13287-022-03147-w","volume":"13","author":"H Feng","year":"2022","unstructured":"Feng H, Liu Q, Deng Z et al (2022) Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis. Stem Cell Res Ther 13(1):450","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9030_CR127","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","volume":"6","author":"TF Davies","year":"2020","unstructured":"Davies TF, Andersen S, Latif R et al (2020) Graves\u2019 disease. Nat Rev Dis Primers 6(1):52","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"9030_CR128","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185(4):G43-g67","journal-title":"Eur J Endocrinol"},{"key":"9030_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.929750","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Jiang W, Lu G et al (2022) Insight into mouse models of hyperthyroidism. Front Endocrinol 13:929750","journal-title":"Front Endocrinol"},{"issue":"1","key":"9030_CR130","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13287-020-01982-3","volume":"11","author":"JY Kim","year":"2020","unstructured":"Kim JY, Park S, Lee HJ et al (2020) Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves\u2019 ophthalmopathy. Stem Cell Res Ther 11(1):469","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9030_CR131","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13287-021-02337-2","volume":"12","author":"M Park","year":"2021","unstructured":"Park M, Kim JY, Kang JM et al (2021) PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves\u2019 ophthalmopathy through SREBP2\/HMGCR pathway. Stem Cell Res Ther 12(1):304","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR132","doi-asserted-by":"crossref","unstructured":"Shin HA, Park M, Banga JP, et al. (2022) TGF\u03b2-treated placenta-derived mesenchymal stem cells selectively promote anti-adipogenesis in thyroid-associated ophthalmopathy. International Journal of Molecular Sciences;23(10).","DOI":"10.3390\/ijms23105603"},{"issue":"1","key":"9030_CR133","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","volume":"60","author":"M Carbone","year":"2014","unstructured":"Carbone M, Neuberger JM (2014) Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol 60(1):210\u2013223","journal-title":"J Hepatol"},{"issue":"1","key":"9030_CR134","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13287-021-02464-w","volume":"12","author":"A Lotfy","year":"2021","unstructured":"Lotfy A, Elgamal A, Burdzinska A et al (2021) Stem cell therapies for autoimmune hepatitis. Stem Cell Res Ther 12(1):386","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"9030_CR135","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/hum.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H et al (2018) Interleukin-35 gene-modified mesenchymal stem cells protect concanavalin A-induced fulminant hepatitis by decreasing the interferon gamma level. Hum Gene Ther 29(2):234\u2013241","journal-title":"Hum Gene Ther"},{"issue":"1","key":"9030_CR136","volume":"19","author":"W Chen","year":"2024","unstructured":"Chen W, Lin F, Feng X et al (2024) MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation. Asian J Pharm Sci 19(1):100889","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"9030_CR137","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10238-010-0105-6","volume":"11","author":"D Wang","year":"2011","unstructured":"Wang D, Zhang H, Liang J et al (2011) Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model. Clin Exp Med 11(1):25\u201332","journal-title":"Clin Exp Med"},{"key":"9030_CR138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","volume":"9","author":"CP Mavragani","year":"2014","unstructured":"Mavragani CP, Moutsopoulos HM (2014) Sj\u00f6gren\u2019s syndrome. Annu Rev Pathol 9:273\u2013285","journal-title":"Annu Rev Pathol"},{"key":"9030_CR139","doi-asserted-by":"crossref","unstructured":"Chihaby N, Orliaguet M, Le Pottier L, et al. (2021) Treatment of Sj\u00f6gren\u2019s syndrome with mesenchymal stem cells: a systematic review. International Journal of Molecular Sciences;22(19).","DOI":"10.3390\/ijms221910474"},{"issue":"1","key":"9030_CR140","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13287-020-01837-x","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi J, Tang X, Li W et al (2020) Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2\/PGE2 in experimental sialadenitis. Stem Cell Res Ther 11(1):325","journal-title":"Stem Cell Res Ther"},{"issue":"26","key":"9030_CR141","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.7150\/thno.37351","volume":"9","author":"G Yao","year":"2019","unstructured":"Yao G, Qi J, Liang J et al (2019) Mesenchymal stem cell transplantation alleviates experimental Sj\u00f6gren\u2019s syndrome through IFN-\u03b2\/IL-27 signaling axis. Theranostics 9(26):8253\u20138265","journal-title":"Theranostics"},{"issue":"1","key":"9030_CR142","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13287-018-1023-x","volume":"9","author":"B Shi","year":"2018","unstructured":"Shi B, Qi J, Yao G et al (2018) Mesenchymal stem cell transplantation ameliorates Sj\u00f6gren\u2019s syndrome via suppressing IL-12 production by dendritic cells. Stem Cell Res Ther 9(1):308","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR143","doi-asserted-by":"crossref","unstructured":"Shin S, Yoon SG, Kim M, et al. (2023) The effect of mesenchymal stem cells on dry eye in sjogren syndrome mouse model. International Journal of Molecular Sciences;24(2).","DOI":"10.3390\/ijms24021039"},{"issue":"9","key":"9030_CR144","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/sctm.21-0021","volume":"10","author":"LT Wang","year":"2021","unstructured":"Wang LT, Liu KJ, Sytwu HK et al (2021) Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med 10(9):1288\u20131303","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"9030_CR145","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G et al (2018) Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 154(5):1334\u201342.e4","journal-title":"Gastroenterology"},{"issue":"1","key":"9030_CR146","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes GM, Sturm MJ, Leong RW et al (2014) A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 12(1):64\u201371","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"10051","key":"9030_CR147","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet (London, England) 388(10051):1281\u20131290","journal-title":"Lancet (London, England)"},{"issue":"3","key":"9030_CR148","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjac144","volume":"17","author":"S Furukawa","year":"2023","unstructured":"Furukawa S, Mizushima T, Nakaya R et al (2023) Darvadstrocel for complex perianal fistulas in Japanese adults with Crohn\u2019s disease: a phase 3 study. Journal of Crohn\u2019s & colitis 17(3):369\u2013378","journal-title":"Journal of Crohn\u2019s & colitis"},{"issue":"2","key":"9030_CR149","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P, Kolappan M, Crawley C et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. The Lancet Neurology 11(2):150\u2013156","journal-title":"The Lancet Neurology"},{"issue":"12","key":"9030_CR150","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou P, Kassis I, Levin N et al (2020) Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain\u202f: a journal of neurology 143(12):3574\u20133588","journal-title":"Brain : a journal of neurology"},{"key":"9030_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103779","volume":"61","author":"JA Berard","year":"2022","unstructured":"Berard JA, Freedman MS, Marrie RA et al (2022) Mesenchymal stem cell therapy and cognition in MS: preliminary findings from a phase II clinical trial. Multiple sclerosis and related disorders 61:103779","journal-title":"Multiple sclerosis and related disorders"},{"issue":"1","key":"9030_CR152","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13287-022-02763-w","volume":"13","author":"R Vij","year":"2022","unstructured":"Vij R, Stebbings KA, Kim H et al (2022) Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I\/IIa, open-label, non-randomized pilot trial. Stem Cell Res Ther 13(1):88","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR153","doi-asserted-by":"crossref","unstructured":"Ghoryani M, Shariati-Sarabi Z, Tavakkol-Afshari J, et al. (2019) Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: a successful clinical trial in Iran. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie;109:1834\u201340.","DOI":"10.1016\/j.biopha.2018.11.056"},{"issue":"1","key":"9030_CR154","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R et al (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis 76(1):196\u2013202","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9030_CR155","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/art.42081","volume":"74","author":"GS Gilkeson","year":"2022","unstructured":"Gilkeson GS (2022) Safety and efficacy of mesenchymal stromal cells and other cellular therapeutics in rheumatic diseases in 2022: a review of what we know so far. Arthritis & rheumatology (Hoboken, NJ) 74(5):752\u2013765","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"1","key":"9030_CR156","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","volume":"7","author":"L Cheng","year":"2022","unstructured":"Cheng L, Wang S, Peng C et al (2022) Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study. Signal Transduct Target Ther 7(1):263","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"9030_CR157","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","volume":"74","author":"B Granel","year":"2015","unstructured":"Granel B, Daumas A, Jouve E et al (2015) Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis 74(12):2175\u20132182","journal-title":"Ann Rheum Dis"},{"key":"9030_CR158","doi-asserted-by":"crossref","unstructured":"Wang L, Li J, Liu H, et al. (2013) Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. Journal of gastroenterology and hepatology;28 Suppl 1:85\u201392.","DOI":"10.1111\/jgh.12029"},{"issue":"1","key":"9030_CR159","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M et al (2022) Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. Stem Cell Res Ther 13(1):264","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"9030_CR160","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"Carlsson PO, Espes D, Sisay S et al (2023) Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial. Diabetologia 66(8):1431\u20131441","journal-title":"Diabetologia"},{"key":"9030_CR161","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3389\/fimmu.2020.00993","volume":"11","author":"DB Araujo","year":"2020","unstructured":"Araujo DB, Dantas JR, Silva KR et al (2020) Allogenic adipose tissue-derived stromal\/stem cells and vitamin D supplementation in patients with recent-onset type 1 diabetes mellitus: a 3-month follow-up pilot study. Front Immunol 11:993","journal-title":"Front Immunol"},{"issue":"8","key":"9030_CR162","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B et al (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69(8):1423\u20131429","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"9030_CR163","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13287-018-1053-4","volume":"9","author":"J Liang","year":"2018","unstructured":"Liang J, Zhang H, Kong W et al (2018) Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Res Ther 9(1):312","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"9030_CR164","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","volume":"76","author":"D Deng","year":"2017","unstructured":"Deng D, Zhang P, Guo Y et al (2017) A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann Rheum Dis 76(8):1436\u20131439","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"9030_CR165","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/ar4520","volume":"16","author":"D Wang","year":"2014","unstructured":"Wang D, Li J, Zhang Y et al (2014) Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study. Arthritis Res Ther 16(2):R79","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"9030_CR166","first-page":"213","volume":"34","author":"E Kara\u00f6z","year":"2017","unstructured":"Kara\u00f6z E, \u00c7etinalp Demircan P, Erman G et al (2017) Comparative analyses of immunosuppressive characteristics of bone-marrow, Wharton\u2019s jelly, and adipose tissue-derived human mesenchymal stem cells. Turkish journal of haematology\u202f: official journal of Turkish Society of Haematology 34(3):213\u2013225","journal-title":"Turkish journal of haematology : official journal of Turkish Society of Haematology"},{"issue":"19","key":"9030_CR167","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer H, Br\u00f6ske AM, Leddin M et al (2013) Mesenchymal stromal cell characteristics vary depending on their origin. Stem cells and development 22(19):2606\u20132618","journal-title":"Stem cells and development"},{"issue":"2","key":"9030_CR168","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11684-018-0627-y","volume":"13","author":"S Wang","year":"2019","unstructured":"Wang S, Zhu R, Li H et al (2019) Mesenchymal stem cells and immune disorders: from basic science to clinical transition. Frontiers of medicine 13(2):138\u2013151","journal-title":"Frontiers of medicine"},{"issue":"6","key":"9030_CR169","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1002\/jcp.27833","volume":"234","author":"L Aghebati-Maleki","year":"2019","unstructured":"Aghebati-Maleki L, Dolati S, Zandi R et al (2019) Prospect of mesenchymal stem cells in therapy of osteoporosis: a review. J Cell Physiol 234(6):8570\u20138578","journal-title":"J Cell Physiol"},{"key":"9030_CR170","doi-asserted-by":"crossref","unstructured":"Fujita Y, Kadota T, Araya J, et al. (2018) Clinical application of mesenchymal stem cell-derived extracellular vesicle-based therapeutics for inflammatory lung diseases. Journal of Clinical Medicine;7(10).","DOI":"10.3390\/jcm7100355"},{"issue":"2","key":"9030_CR171","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1582-4934.2007.00146.x","volume":"12","author":"LA Meza-Zepeda","year":"2008","unstructured":"Meza-Zepeda LA, Noer A, Dahl JA et al (2008) High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12(2):553\u2013563","journal-title":"J Cell Mol Med"},{"issue":"1","key":"9030_CR172","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-016-0383-3","volume":"7","author":"R Fazzina","year":"2016","unstructured":"Fazzina R, Iudicone P, Fioravanti D et al (2016) Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues. Stem Cell Res Ther 7(1):122","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR173","doi-asserted-by":"publisher","first-page":"8329174","DOI":"10.1155\/2018\/8329174","volume":"2018","author":"T Sultana","year":"2018","unstructured":"Sultana T, Lee S, Yoon HY et al (2018) Current status of canine umbilical cord blood-derived mesenchymal stem cells in veterinary medicine. Stem Cells International 2018:8329174","journal-title":"Stem Cells International"},{"issue":"6","key":"9030_CR174","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22(6):824\u2013833","journal-title":"Cell Stem Cell"},{"key":"9030_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100967","volume":"85","author":"JY Oh","year":"2021","unstructured":"Oh JY, Lee RH (2021) Mesenchymal stromal cells for the treatment of ocular autoimmune diseases. Prog Retin Eye Res 85:100967","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"9030_CR176","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1182\/blood-2006-01-0057","volume":"107","author":"JL Chan","year":"2006","unstructured":"Chan JL, Tang KC, Patel AP et al (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107(12):4817\u20134824","journal-title":"Blood"},{"issue":"5","key":"9030_CR177","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5):1755\u20131761","journal-title":"Blood"},{"issue":"10","key":"9030_CR178","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/stem.194","volume":"27","author":"G Constantin","year":"2009","unstructured":"Constantin G, Marconi S, Rossi B et al (2009) Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem cells (Dayton, Ohio) 27(10):2624\u20132635","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"6","key":"9030_CR179","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.copbio.2012.05.005","volume":"23","author":"O DelaRosa","year":"2012","unstructured":"DelaRosa O, Dalemans W, Lombardo E (2012) Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol 23(6):978\u2013983","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"9030_CR180","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","volume":"28","author":"WZ Zhuang","year":"2021","unstructured":"Zhuang WZ, Lin YH, Su LJ et al (2021) Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci 28(1):28","journal-title":"J Biomed Sci"},{"issue":"11","key":"9030_CR181","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41419-022-05445-w","volume":"13","author":"Y Ding","year":"2022","unstructured":"Ding Y, Gong P, Jiang J et al (2022) Mesenchymal stem\/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis. Cell Death Dis 13(11):996","journal-title":"Cell Death Dis"},{"issue":"1","key":"9030_CR182","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13287-020-01920-3","volume":"11","author":"BC Lee","year":"2020","unstructured":"Lee BC, Kang KS (2020) Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Res Ther 11(1):397","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9030_CR183","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41420-022-01264-2","volume":"8","author":"P Gong","year":"2022","unstructured":"Gong P, Ding Y, Sun R et al (2022) Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages. Cell Death Discovery 8(1):466","journal-title":"Cell Death Discovery"},{"key":"9030_CR184","doi-asserted-by":"crossref","unstructured":"Lee HK, Kim HS, Pyo M, et al. (2020) Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas(lpr) mice. Theranostics;10(22):10186\u201399.","DOI":"10.7150\/thno.46835"},{"key":"9030_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792739","volume":"12","author":"S Matsuda","year":"2021","unstructured":"Matsuda S, Kotani T, Saito T et al (2021) Low-molecular-weight heparin enhanced therapeutic effects of human adipose-derived stem cell administration in a mouse model of lupus nephritis. Front Immunol 12:792739","journal-title":"Front Immunol"},{"issue":"6","key":"9030_CR186","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/rheumatology\/kez631","volume":"59","author":"SG Jang","year":"2020","unstructured":"Jang SG, Lee J, Hong SM et al (2020) Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus. Rheumatology (Oxford) 59(6):1426\u20131438","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"9030_CR187","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/scrt228","volume":"4","author":"Y Hou","year":"2013","unstructured":"Hou Y, Ryu CH, Park KY et al (2013) Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice. Stem Cell Res Ther 4(4):77","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117420","volume":"246","author":"E Moases Ghaffary","year":"2020","unstructured":"Moases Ghaffary E, Abtahi Froushani SM (2020) Immunomodulatory benefits of mesenchymal stem cells treated with caffeine in adjuvant-induced arthritis. Life Sci 246:117420","journal-title":"Life Sci"},{"key":"9030_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111662","volume":"129","author":"B Isildar","year":"2024","unstructured":"Isildar B, Ozkan S, Sahin H et al (2024) Preconditioning of human umbilical cord mesenchymal stem cells with deferoxamine potentiates the capacity of the secretome released from the cells and promotes immunomodulation and beta cell regeneration in a rat model of type 1 diabetes. Int Immunopharmacol 129:111662","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"9030_CR190","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.tibtech.2023.01.003","volume":"41","author":"PM Pincela Lins","year":"2023","unstructured":"Pincela Lins PM, Pirlet E, Szymonik M et al (2023) Manufacture of extracellular vesicles derived from mesenchymal stromal cells. Trends Biotechnol 41(7):965\u2013981","journal-title":"Trends Biotechnol"},{"key":"9030_CR191","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3389\/fimmu.2019.02663","volume":"10","author":"MO Gomzikova","year":"2019","unstructured":"Gomzikova MO, James V, Rizvanov AA (2019) Therapeutic application of mesenchymal stem cells derived extracellular vesicles for immunomodulation. Front Immunol 10:2663","journal-title":"Front Immunol"},{"issue":"11","key":"9030_CR192","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.7150\/thno.42742","volume":"10","author":"S Kim","year":"2020","unstructured":"Kim S, Maeng JY, Hyun SJ et al (2020) Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis. Theranostics 10(11):5011\u20135028","journal-title":"Theranostics"},{"issue":"1","key":"9030_CR193","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Johnson-Stephenson TK, Wang W et al (2022) Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell. Stem Cell Res Ther 13(1):484","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108634","volume":"106","author":"H Huldani","year":"2022","unstructured":"Huldani H, Abdalkareem Jasim S, Olegovich Bokov D et al (2022) Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. Int Immunopharmacol 106:108634","journal-title":"Int Immunopharmacol"},{"key":"9030_CR195","doi-asserted-by":"crossref","unstructured":"B\u00f6rger V, Bremer M, Ferrer-Tur R, et al. (2017) Mesenchymal stem\/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. International Journal of Molecular Sciences;18(7).","DOI":"10.3390\/ijms18071450"},{"key":"9030_CR196","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jot.2024.07.005","volume":"48","author":"J Wu","year":"2024","unstructured":"Wu J, Wu J, Liu Z et al (2024) Mesenchymal stem cell-derived extracellular vesicles in joint diseases: therapeutic effects and underlying mechanisms. Journal of orthopaedic translation 48:53\u201369","journal-title":"Journal of orthopaedic translation"},{"issue":"1","key":"9030_CR197","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-023-03295-7","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu X, Ma D, Yang B et al (2023) Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune\/inflammatory diseases. Stem Cell Res Ther 14(1):71","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9030_CR198","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13287-021-02402-w","volume":"12","author":"ST Wei","year":"2021","unstructured":"Wei ST, Huang YC, Chiang JY et al (2021) Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation. Stem Cell Res Ther 12(1):314","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"9030_CR199","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/bph.13674","volume":"174","author":"C Marin-Ba\u00f1asco","year":"2017","unstructured":"Marin-Ba\u00f1asco C, Benabdellah K, Melero-Jerez C et al (2017) Gene therapy with mesenchymal stem cells expressing IFN-\u00df ameliorates neuroinflammation in experimental models of multiple sclerosis. Br J Pharmacol 174(3):238\u2013253","journal-title":"Br J Pharmacol"},{"issue":"12","key":"9030_CR200","doi-asserted-by":"publisher","first-page":"10381","DOI":"10.1007\/s12035-024-04211-7","volume":"61","author":"N Maleki","year":"2024","unstructured":"Maleki N, Rezapour Kalkhoran M, Emami Aleagha MS et al (2024) Enhanced therapeutic effects of human mesenchymal stem cells transduced with secreted klotho in a murine experimental autoimmune encephalomyelitis model. Mol Neurobiol 61(12):10381\u201310397","journal-title":"Mol Neurobiol"},{"issue":"1","key":"9030_CR201","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-024-03134-3","volume":"21","author":"F Yuan","year":"2024","unstructured":"Yuan F, Zhang R, Li J et al (2024) CCR5-overexpressing mesenchymal stem cells protect against experimental autoimmune uveitis: insights from single-cell transcriptome analysis. J Neuroinflammation 21(1):136","journal-title":"J Neuroinflammation"},{"issue":"10","key":"9030_CR202","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12361","volume":"12","author":"R Huang","year":"2023","unstructured":"Huang R, Jia B, Su D et al (2023) Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders. Journal of Extracellular Vesicles 12(10):e12361","journal-title":"Journal of Extracellular Vesicles"},{"issue":"1","key":"9030_CR203","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12951-024-02711-1","volume":"22","author":"Q Yan","year":"2024","unstructured":"Yan Q, Liu H, Sun S et al (2024) Adipose-derived stem cell exosomes loaded with icariin alleviates rheumatoid arthritis by modulating macrophage polarization in rats. Journal of nanobiotechnology 22(1):423","journal-title":"Journal of nanobiotechnology"},{"issue":"20","key":"9030_CR204","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1021\/acsnano.4c02420","volume":"18","author":"W Ma","year":"2024","unstructured":"Ma W, Che J, Chen W et al (2024) Dexamethasone-integrated mesenchymal stem cells for systemic lupus erythematosus treatment via multiple immunomodulatory mechanisms. ACS Nano 18(20):13249\u201313265","journal-title":"ACS Nano"},{"issue":"1","key":"9030_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202106265","volume":"34","author":"F Xu","year":"2022","unstructured":"Xu F, Fei Z, Dai H et al (2022) Mesenchymal stem cell-derived extracellular vesicles with high PD-L1 expression for autoimmune diseases treatment. Advanced materials (Deerfield Beach, Fla) 34(1):e2106265","journal-title":"Advanced materials (Deerfield Beach, Fla)"},{"issue":"38","key":"9030_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301019","volume":"19","author":"L Wang","year":"2023","unstructured":"Wang L, Qi C, Cao H et al (2023) Engineered cytokine-primed extracellular vesicles with high PD-L1 expression ameliorate type 1 diabetes. Small 19(38):e2301019","journal-title":"Small"},{"key":"9030_CR207","doi-asserted-by":"crossref","unstructured":"You DG, Lim GT, Kwon S, et al. (2021) Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Science Advances;7(23).","DOI":"10.1126\/sciadv.abe0083"},{"issue":"7","key":"9030_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001948","volume":"10","author":"ME Wechsler","year":"2021","unstructured":"Wechsler ME, Rao VV, Borelli AN et al (2021) Engineering the MSC secretome: a hydrogel focused approach. Adv Healthcare Mater 10(7):e2001948","journal-title":"Adv Healthcare Mater"},{"key":"9030_CR209","doi-asserted-by":"crossref","unstructured":"Sendon-Lago J, Rio LG, Eiro N, et al. (2021) Tailored hydrogels as delivery platforms for conditioned medium from mesenchymal stem cells in a model of acute colitis in mice. Pharmaceutics;13(8).","DOI":"10.3390\/pharmaceutics13081127"},{"issue":"6","key":"9030_CR210","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2023.04.003","volume":"13","author":"G Shi","year":"2023","unstructured":"Shi G, Zhou Y, Liu W et al (2023) Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A(2A\/2B) receptors in tolerogenic dendritic cells. Acta pharmaceutica Sinica B 13(6):2778\u20132794","journal-title":"Acta pharmaceutica Sinica B"},{"key":"9030_CR211","doi-asserted-by":"publisher","first-page":"8850820","DOI":"10.1155\/2021\/8850820","volume":"2021","author":"Q Zhai","year":"2021","unstructured":"Zhai Q, Dong J, Zhang X et al (2021) Mesenchymal stem cells enhance therapeutic effect and prevent adverse gastrointestinal reaction of methotrexate treatment in collagen-induced arthritis. Stem Cells International 2021:8850820","journal-title":"Stem Cells International"},{"key":"9030_CR212","doi-asserted-by":"crossref","unstructured":"Zhou Z, Li Y, Wu S, et al. (2024) Host-microbiota interactions in collagen-induced arthritis rats treated with human umbilical cord mesenchymal stem cell exosome and ginsenoside Rh2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie;174:116515.","DOI":"10.1016\/j.biopha.2024.116515"},{"issue":"28","key":"9030_CR213","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021222","volume":"99","author":"T Qi","year":"2020","unstructured":"Qi T, Gao H, Dang Y et al (2020) Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis. Medicine 99(28):e21222","journal-title":"Medicine"},{"issue":"11","key":"9030_CR214","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304333","volume":"36","author":"MJ Shin","year":"2024","unstructured":"Shin MJ, Park JY, Park JY et al (2024) Inflammation-targeting mesenchymal stem cells combined with photothermal treatment attenuate severe joint inflammation. Advanced materials (Deerfield Beach, Fla) 36(11):e2304333","journal-title":"Advanced materials (Deerfield Beach, Fla)"},{"key":"9030_CR215","doi-asserted-by":"publisher","first-page":"1033498","DOI":"10.3389\/fimmu.2022.1033498","volume":"13","author":"X Lu","year":"2022","unstructured":"Lu X, Wang H, Wang H et al (2022) Indirubin combined with umbilical cord mesenchymal stem cells to relieve psoriasis-like skin lesions in BALB\/c mice. Front Immunol 13:1033498","journal-title":"Front Immunol"},{"issue":"1","key":"9030_CR216","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13287-017-0690-3","volume":"8","author":"F Virz\u00ec","year":"2017","unstructured":"Virz\u00ec F, Bianca P, Giammona A et al (2017) Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients. Stem Cell Res Ther 8(1):236","journal-title":"Stem Cell Res Ther"},{"key":"9030_CR217","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2021.03.003","volume":"233","author":"I Kassis","year":"2021","unstructured":"Kassis I, Ben-Zwi M, Petrou P et al (2021) Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis. Immunol Lett 233:11\u201319","journal-title":"Immunol Lett"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09030-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:39:25Z","timestamp":1740148765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09030-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9030"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09030-9","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"4 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors consent to publish the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"21"}}